Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation

about

Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation

Item

http://www.wikidata.org/entity/Q58803514

description

article

@en

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Hypomagnesemia in diabetes pat ...... n and its role in inflammation

@en

Hypomagnesemia in diabetes pat ...... n and its role in inflammation

@nl

type

Item

label

Hypomagnesemia in diabetes pat ...... n and its role in inflammation

@en

Hypomagnesemia in diabetes pat ...... n and its role in inflammation

@nl

prefLabel

Hypomagnesemia in diabetes pat ...... n and its role in inflammation

@en

Hypomagnesemia in diabetes pat ...... n and its role in inflammation

@nl

P1476

Hypomagnesemia in diabetes pat ...... n and its role in inflammation

@en

P2093

Burton Silver

http://www.w3.org/2001/XMLSchema#string

Ivan Tong Mak

http://www.w3.org/2001/XMLSchema#string

Nadia Zghoul

http://www.w3.org/2001/XMLSchema#string

William B Weglicki

http://www.w3.org/2001/XMLSchema#string

P2860

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?

Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials.

Mechanism of hypokalemia in magnesium deficiency.

EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade

Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

Loss of neutral endopeptidase activity contributes to neutrophil activation and cardiac dysfunction during chronic hypomagnesemia: Protection by substance P receptor blockade

The antioxidant effects of statins.

Development of cellular magnesium nano-analysis in treatment of clinical magnesium deficiency.

Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?

P304

389-400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DMSO.S168398

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nada Alam-Eldin

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30122966

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

Béésh Łikoní

P932

6080849

http://www.w3.org/2001/XMLSchema#string